Cargando…

Incidental pharmacogenetics findings in an HLA‐related research: Considerations for primary prevention

Detalles Bibliográficos
Autores principales:	Bakhtiar, Mohammed Faizal, Too, Chun‐Lai, Tang, Min‐Moon, Sulaiman, Salsabil, Tan, Lay‐Kim, Ahmad‐Fauzi, Nurul Aain, Kwok, Fan‐Yin, Murad, Shahnaz, Rayyapa, Giriyappanavar Chandrashekar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849724/ https://www.ncbi.nlm.nih.gov/pubmed/30693574 http://dx.doi.org/10.1111/cea.13347

Ejemplares similares

Tropomyosin, the major tropical oyster Crassostrea belcheri allergen and effect of cooking on its allergenicity
por: Yadzir, Zailatul Hani Mohamad, et al.
Publicado: (2015)

Tropomyosin and Actin Identified as Major Allergens of the Carpet Clam (Paphia textile) and the Effect of Cooking on Their Allergenicity
por: Mohamad Yadzir, Zailatul Hani, et al.
Publicado: (2015)

Incidental Findings in Neuroimaging: Ethical and Medicolegal Considerations
por: Leung, Lawrence
Publicado: (2013)

HLA Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population
por: Nakkam, Nontaya, et al.
Publicado: (2018)

The spectrum of association in HLA region with rheumatoid arthritis in a diverse Asian population: evidence from the MyEIRA case-control study
por: Tan, Lay Kim, et al.
Publicado: (2021)

Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations
por: Eum, Seenae, et al.
Publicado: (2016)

Ethical Considerations for the Return of Incidental Findings in Ophthalmic Genomic Research
por: Souzeau, Emmanuelle, et al.
Publicado: (2016)

Funding considerations for the disclosure of genetic incidental findings in biobank research
por: Black, L, et al.
Publicado: (2013)

Recognizing Rheumatoid Arthritis: Oncoprotein Survivin Opens New Possibilities: A Population-based Case–Control Study
por: Chun-Lai, Too, et al.
Publicado: (2015)

ACE2 and COVID-19: using antihypertensive medications and pharmacogenetic considerations
por: Snyder, Eric M, et al.
Publicado: (2020)

Diversity In Precision Medicine And Pharmacogenetics: Methodological And Conceptual Considerations For Broadening Participation
por: Popejoy, Alice B
Publicado: (2019)

Genome-wide analyses disclose the distinctive HLA architecture and the pharmacogenetic landscape of the Somali population
por: Ali, Abshir A., et al.
Publicado: (2020)

Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine
por: Girardin, François R., et al.
Publicado: (2018)

Direct PCR: a new pharmacogenetic approach for the inexpensive testing of HLA-B*57:01
por: Cascella, R, et al.
Publicado: (2015)

Cost effectiveness of pharmacogenetic-guided clozapine administration based on risk of HLA variants in Japan and the UK
por: Ninomiya, Kohei, et al.
Publicado: (2021)

Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations
por: Choi, Rihwa, et al.
Publicado: (2017)

Exploring the Causal Relationship Between Telomere Biology and Alzheimer’s Disease
por: Kuan, Xi-Yuen, et al.
Publicado: (2023)

Smoking interacts with HLA-DRB1 shared epitope in the development of anti-citrullinated protein antibody-positive rheumatoid arthritis: results from the Malaysian Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA)
por: Too, Chun Lai, et al.
Publicado: (2012)

Cancer pharmacogenetics
por: Marsh, S, et al.
Publicado: (2004)

Experimental Pharmacogenetics
por: Lubs, Herbert A.
Publicado: (1964)

Pharmacogenetics of Anticoagulants
por: Rane, Anders, et al.
Publicado: (2010)

Pharmacogenetics of osteoporosis
por: Marini, Francesca, et al.
Publicado: (2010)

The pharmacogenetics of imatinib
por: Dulucq, Stéphanie, et al.
Publicado: (2010)

Pharmacogenetics of Antidepressants
por: Crisafulli, Concetta, et al.
Publicado: (2011)

Pharmacogenetics in the clinic
por: Guchelaar, H.-J.
Publicado: (2013)

Pharmacogenetics of Cannabinoids
por: Hryhorowicz, Szymon, et al.
Publicado: (2017)

Pharmacogenetics of thiopurines
por: Franca, Raffaella, et al.
Publicado: (2019)

Ultrarapid and high-resolution HLA class I typing using transposase-based nanopore sequencing applied in pharmacogenetic testing
por: Anukul, Nampeung, et al.
Publicado: (2023)

Association between HLA-B*1502 allele and aromatic antiepileptic drugs-induced hypersensitivity syndrome reactions and the HLA-B*15:02 pharmacogenetics screening in autistic spectrum disorder
por: Sukasem, Chonlaphat, et al.
Publicado: (2014)

Polyorchidism: An incidental finding
por: Sen, Jyotsna, et al.
Publicado: (2009)

Editorial: Editor’s feature: negative findings in pharmacogenetics and pharmacogenomics
por: Agúndez, José A. G., et al.
Publicado: (2023)

Genome-wide pharmacogenetics of anti-drug antibody response to bococizumab highlights key residues in HLA DRB1 and DQB1
por: Chasman, Daniel I., et al.
Publicado: (2022)

Pharmacogenetics in the Brazilian Population
por: Suarez-Kurtz, Guilherme
Publicado: (2010)

Pharmacogenetics – Getting Closer
por: MacDonald, Ian M
Publicado: (2009)

Pharmacogenetics: The future medicine
por: Saini, Rajiv, et al.
Publicado: (2010)

Pharmacogenetics of asthma in children
por: Kondo, Naomi, et al.
Publicado: (2010)

Pharmacogenetics of lipid diseases
por: Ordovas, Jose M
Publicado: (2004)

Pharmacogenetics of analgesic drugs
por: Cregg, Roman, et al.
Publicado: (2013)

Pharmacogenetics of Antiplatelet Drugs
por: Curtin, Ronan, et al.
Publicado: (2002)

Pharmacogenetic research in Kazakhstan
por: Zholdybayeva, Elena, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sg491tc5sb4elkdtu4msu9f3d9